The SUMOylation of TAB2 Mediated by TRIM60 Inhibits MAPK/NF-κB Activation and the Innate Immune Response
Zhiwen Gu,Xueying Chen,Wenyong Yang,Yu Qi,Hui Yu,Xiaomeng Wang,Yanqiu Gong,Qianqian Chen,Bo Zhong,Lunzhi Dai,Shiqian Qi,Zhiqiang Zhang,Huiyuan Zhang,Hongbo Hu
DOI: https://doi.org/10.1038/s41423-020-00564-w
2020-01-01
Cellular and Molecular Immunology
Abstract:Activation of the TAK1 signalosome is crucial for mediating the innate immune response to pathogen invasion and is regulated by multiple layers of posttranslational modifications,including ubiquitination,SUMOylation,and phosphorylation;however,the underlying molecular mechanism is not fully understood.In this study,TRIM60 negatively regulated the formation and activation of the TAK1 signalosome.Deficiency of TRIM60 in macrophages led to enhanced MAPK and NF-κB activation,accompanied by elevated levels of proinflammatory cytokines but not IFN-I.Immunoprecipitation-mass spectrometry assays identified TAB2 as the target of TRIM60 for SUMOylation rather than ubiquitination,resulting in impaired formation of the TRAF6/TAB2/TAK1 complex and downstream MAPK and NF-κB pathways.The SUMOylation sites of TAB2 mediated by TRIM60 were identified as K329 and K562;substitution of these lysines with arginines abolished the SUMOylation of TAB2.In vivo experiments showed that TRIM60-deficient mice showed an elevated immune response to LPS-induced septic shock and L.monocytogenes infection.Our data reveal that SUMOylation of TAB2 mediated by TRIM60 is a novel mechanism for regulating the innate immune response,potentially paving the way for a new strategy to control antibacterial immune responses.